$24.53 -0.02 (-0.08%)
iShares Genomics Immunology and Healthcare ETF (IDNA)
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| June 20, 2025 | $0.15 | 2025-06-16 | 2025-06-16 |
| December 20, 2024 | $0.11 | 2024-12-17 | 2024-12-17 |
| June 17, 2024 | $0.11 | 2024-06-11 | 2024-06-11 |
| December 27, 2023 | $0.17 | 2023-12-20 | 2023-12-21 |
| June 13, 2023 | $0.07 | 2023-06-07 | 2023-06-08 |
Dividends Summary
- iShares Genomics Immunology and Healthcare ETF has issued 11 dividend payments over the past 6 years
- The most recent dividend was paid 126 days ago, on June 20, 2025
- The highest dividend payed out to investors during this period was $0.26 per share
- The average dividend paid during this period was $0.13 per share.
Company News
Merck Germany Buys US Cancer Drugmaker SpringWorks Therapeutics For Around $4 Billion
Merck & Co. has agreed to acquire SpringWorks Therapeutics for around $4 billion, a 26% premium over SpringWorks' 20-day average price. The acquisition will boost Merck's revenue and expand its U.S. healthcare presence, particularly in rare tumor treatments.
Top Thematic ETF Ideas for 2024: AI & More
BlackRock's Jay Jacobs discusses best investing themes for 2024.
Top ETFs Tracking CRISPR Gene Editing
These exchange-traded funds track companies in this biotech space.
The Week On Wall Street: The S&P Rolls To Another New High
Sector rotation and rolling corrections continue, further complicating the investment backdrop. As the Fed starts to “taper”, no one can claim they were shocked. Read more here.
‘Proceed with caution’: here's what Wall Street analysts see for the U.S. stock market in 2022
The recent spike in market volatility may herald a bumpier U.S. stock market in 2022, as investors come to grips with an inflection point in monetary policy in the pandemic.